Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway

MLA

Ai-Ni, Tsao, et al. “Dinaciclib Inhibits the Stemness of Two Subtypes of Human Breast Cancer Cells by Targeting the FoxM1 and Hedgehog Signaling Pathway.” Oncology Reports, vol. 47, Apr. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8a9f9a3b2554d7683ad8bb475fbd6712&authtype=sso&custid=ns315887.

APA

Ai-Ni, T., Yu-Syuan, C., Yen-Chun, L., Yeu, S., & Ta-Chung, C. (2022). Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway. Oncology Reports, 47.

Chicago

Ai-Ni, Tsao, Chuang Yu-Syuan, Lin Yen-Chun, Su Yeu, and Chao Ta-Chung. 2022. “Dinaciclib Inhibits the Stemness of Two Subtypes of Human Breast Cancer Cells by Targeting the FoxM1 and Hedgehog Signaling Pathway.” Oncology Reports 47 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8a9f9a3b2554d7683ad8bb475fbd6712&authtype=sso&custid=ns315887.